CLINICAL_TRIALS
trial_result
· 2022-04-06
Clinical Trial Update: Efficacy and Safety of Sitafloxacin in the Treatment of Acute Exacerbation of Bronchiectasis in Adults [Phase 4]
Summary
Phase 4 trial evaluating the efficacy and safety of sitafloxacin for acute exacerbation of bronchiectasis in adults; status is currently unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: Acute Exacerbation of Bronchiectasis | Phase 4 | Status: UNKNOWN